Letter to the EditorFamilial frontotemporal dementia with parkinsonism associated with the progranulin c.C1021T (p.Q341X) mutation☆
References (3)
- et al.
Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia
Lancet Neurol
(2008)
There are more references available in the full text version of this article.
Cited by (7)
Parkinsonian syndrome in familial frontotemporal dementia
2014, Parkinsonism and Related DisordersCitation Excerpt :PGRN mutations are suggested to be one of the most common causes of familial CBS [29]. Parkinsonism seen in FTDP-17 (PGRN) cases may initially respond to levodopa; however, in most cases, it is not levodopa-sensitive [37,38]. The specific PGRN mutations in which parkinsonism are most likely to be observed are summarized in Table 4.
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
2021, Zhurnal Nevrologii i Psihiatrii imeni S.S. KorsakovaThe clinical spectrum of sporadic and familial forms of frontotemporal dementia
2016, Journal of NeurochemistryPhenotypic heterogeneity of monogenic frontotemporal dementia
2015, Frontiers in Aging NeurosciencePhenotypic signatures of genetic frontotemporal dementia
2011, Current Opinion in Neurology
- ☆
The review of this paper was entirely handled by the Co-Editor-in-Chief, Ronald Pfeiffer.
Copyright © 2010 Elsevier Ltd. All rights reserved.